Monitoring of Intracellular l‐βD‐Arabinofuranosylcytosine 5′‐Triphosphate in 1‐β‐D‐Arabinofuranosylcytosine Therapy at Low and Conventional Doses

Documenti analoghi

• Close Correlation of 1‐β‐D‐Arabinofuranosylcytosine 5′‐Triphosphate, an Intracellular Active Metabolite, to the Therapeutic Efficacy of N(4)‐Behenoyl‐1‐β‐D‐arabinofuranosylcytosine Therapy for Acute Myelogenous Leukemia
  di: Yamauchi, Takahiro, et al.
  Pubblicazione: (2001)
• l‐β‐D‐Arabinofuranosylcytosine Is Cytotoxic in Quiescent Normal Lymphocytes Undergoing DNA Excision Repair
  di: Yamauchi, Takahiro, et al.
  Pubblicazione: (2002)
• Modulation of the Effect of l‐β‐D‐Arabinofuranosylcytosine by 6‐Mercaptopurine in L1210 Cells
  di: Kawai, Yasukazu, et al.
  Pubblicazione: (1994)
• Enhancement of Ca(2+)‐dependent Endonuclease Activity in L1210 Cells during Apoptosis Induced by 1‐β‐D‐Arabinofuranosylcytosine: Possible Involvement of Activating Factor(s)
  di: Takauji, Rumiko, et al.
  Pubblicazione: (1995)
• Induction of topoisomerase I cleavage complexes by 1-β-d-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells
  di: Pourquier, Philippe, et al.
  Pubblicazione: (2000)